Results 11 to 20 of about 4,946 (195)

Antimicrobial Susceptibility of 260 Clostridium botulinum Type A, B, Ba, and Bf Strains and a Neurotoxigenic Clostridium baratii Type F Strain Isolated from California Infant Botulism Patients. [PDF]

Antimicrob Agents Chemother, 2018
Barash JR, Castles JB, Arnon SS.
europepmc   +5 more sources

Infant Botulism: A Case Study in Integrated Clinical and Public Health Response. [PDF]

Clin Case Rep
ABSTRACT Early recognition of constipation, feeding difficulty, and descending weakness in infants is vital for prompt diagnosis of infant botulism. Bedside nerve studies support early treatment. Rapid public health notification and coordinated access to specific therapies, including timely use of BAT and BIG‐IV, are essential to optimize outcomes and ...
Gannon J, Fallon Verbruggen T, Burke S, Loughlin L, Brits C, Tedford K, McHugh JC, Mayberry H, O'Regan M, Freyne B, Conroy N.   +10 more
europepmc   +2 more sources

First case of infant botulism in Sicily-case report. [PDF]

Ital J Pediatr
Fazzino A, Cavallaro C, Cavataio F, Linares G, Lo Cascio A, Lo Porto C, Santangelo G, Venuti L, Corsello G, Colomba C.   +9 more
europepmc   +3 more sources

Diversity of the Genomes and Neurotoxins of Strains of Clostridium botulinum Group I and Clostridium sporogenes Associated with Foodborne, Infant and Wound Botulism [PDF]

Toxins, 2020
Jason Brunt, Arnoud H. M. van Vliet, Andrew T. Carter, Sandra C. Stringer, Corinne Amar, Kathie Grant, Gauri Godbole, Michael W. Peck   +7 more
openalex   +3 more sources

Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature [PDF]

, 2017
Botulinum neurotoxins are diverse proteins. They are currently represented by at least seven serotypes and more than 40 subtypes. New clostridial strains that produce novel neurotoxin variants are being identified with increasing frequency, which ...
Anniballi, Fabrizio, Austin, John W., Bano, Luca, Bradshaw, Marite, Cheng, Luisa W., Cuervo, Paula, Derman, Yagmur, Dorner, Brigitte G., Fisher, Audrey, Hill, Karen K., Kalb, Suzanne R., Korkeala, Hannu, Lindström, Miia, Lista, Florigio, Luquez, Carolina, Mazuet, Christelle, Peck, Michael W., Pirazzini, Marco, Popoff, Michel R., Rossetto, Ornella, Rummel, Andreas, Sesardic, Dorothea, Singh, Bal Ram, Smith, Theresa J., Stringer, Sandra C.   +24 more
core   +17 more sources

Infant Honey Feeding and Associating Sociodemographic and Clinical Factors: <i>Are there risks for infant botulism in Oman</i>? [PDF]

Sultan Qaboos Univ Med J
Al Yazeedi B, Al Omari O, Al Yazeedi S.
europepmc   +2 more sources

Infant Botulism in the Very Young Neonate: A Case Series. [PDF]

AJP Rep, 2017
Jackson L, Madan-Khetarpal S, Naik M, Michaels MG, Riley M.   +4 more
europepmc   +3 more sources

Infant Botulism: In Search of Clostridium botulinum Spores. [PDF]

Curr Microbiol
Harris RA, Dabritz HA.
europepmc   +3 more sources

Infant botulism [PDF]

Journal of Perinatology, 2007
Infant botulism results from the absorption of heat-labile neurotoxin produced in situ by ingested Clostridium botulinum. Honey and environmental exposure are the main sources of acquisition of the organism. Clinical manifestations are owing to progressive neuromuscular blockade, initially of muscles innervated by cranial nerves and later of the trunk,
  +5 more sources

A case of infant botulism in a 4-month-old baby [PDF]

, 2016
This case-report highlights: i) the difficulty of IB diagnosis as it is a rare syndrome with subclinical onset, ii) the need for an accurate training for physicians involved in IB management, iii) the efficacy and safety of TEqA in IB treatment, iv ...
Bruna Auricchio, Dilettta Sabatini, Fabrizio Anniballi, GRASSI, Maria Caterina, Laura Papetti, LONATI, DAVIDE, PROPERZI, Enrico   +6 more
core   +1 more source